Eli Casdin
CIK 1534264 · Officer (CEO) · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$576.38M
Companies
15
Total Filings
65
Lifetime Open-Market Net
$89.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | Director | 357,237 | $61.88 | $22.11M | $0 | 1 | 2026-06-23 |
| LAB | Director | 5,797,388 | $0.79 | $4.61M | $34.27M | 14 | 2026-06-23 |
| WGSWW | Director | 3,027,682 | $0.00 | $606 | -$194.68M | 10 | 2025-08-22 |
| BLFS | 10%+ Owner | 16,306,694 | $31.98 | $521.49M | $26.38M | 4 | 2025-04-09 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 2,022,625 | $5.00 | $10.11M | $15.60M | 2 | 2024-06-12 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | 10,138,865 | $0.09 | $871.9K | $0 | 5 | 2023-03-22 |
| EQRx, Inc. (EQRXW) Delisted | Director | 5,488,164 | $0.05 | $249.7K | $0 | 4 | 2023-01-04 |
| MXCT | 10%+ Owner | 10,000,000 | $1.05 | $10.50M | $75.50M | 2 | 2022-10-05 |
| TNYA | Director | 3,224,849 | $0.76 | $2.44M | $12.75M | 2 | 2022-06-13 |
| ABSI | Director | 973,260 | $7.13 | $6.94M | $25.00M | 2 | 2022-06-10 |
| IPSC | Director | 3,206,380 | $2.05 | $6.57M | $15.00M | 3 | 2022-06-10 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Director | 16,450,336 | $0.02 | $394.8K | $45.75M | 6 | 2022-05-12 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 9,045 | $104.91 | $948.9K | $0 | 5 | 2020-07-24 |
| Generation Bio Co. (GBIO) Delisted | 10%+ Owner | 161,122 | $5.34 | $860.4K | $24.70M | 1 | 2020-06-18 |
| FULC | 10%+ Owner | 464,285 | $3.72 | $1.73M | $8.87M | 1 | 2019-07-22 |
Recent Filings · Page 2 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-06 | LAB | Buy (P) | +10,800,000 | $17.54M | EDGAR |
| 2024-08-05 | WGSWW | Other (J) | +1,654,620 | $53.36M | EDGAR |
| 2024-07-23 | LAB | Grant (A) | +1,588 | $0 | EDGAR |
| 2024-07-02 | LAB | Grant (A) | +43,128 | $0 | EDGAR |
| 2024-06-27 | WGSWW | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | WGSWW | Exer (M) | +5,828 | $0 | EDGAR |
| 2024-06-12 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +24,100 | $0 | EDGAR |
| 2024-05-28 | WGSWW | Buy (P) | +850,000 | $17.12M | EDGAR |
| 2024-03-25 | 2seventy bio, Inc. (TSVT) Delisted | Mixed | +3,109,508 | $15.60M | EDGAR |
| 2024-02-22 | LAB | Grant (A) | +22,800 | $57.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.